MT2A and neoplasm: The contribution of single-nucleotide polymorphisms (SNPs) in the MT2A gene to variation in the cellular activities of metallothioneins and the signaling of MT-dependent pathways may steer the enhancement of tumor development and growth toward increased DNA damage, enhanced genomic instability, deregulated cell proliferation, inhibited apoptosis, and induced oxidative stress [6, 8].